重视炎症性肠病远程医疗的价值
远程医疗有多种形式,远程监测是常用方法。Cross等报告了一项设计良好的随机对照试验,评估远程监测项目对炎症性肠病患者的影响,未显示疾病活动度差异,但促使思考远程医疗干预应随访哪些合适结局。若能证明远程医疗以更低成本维持医疗质量,此类干预的价值将最终提升。
要点
- 远程监测是炎症性肠病远程医疗的常用形式。
- Cross等的随机对照试验未显示远程监测组与对照组疾病活动度有差异。
- 需思考远程医疗干预应随访的合适结局。
核心结论
- 该随机对照试验未显示远程监测项目对炎症性肠病患者疾病活动度有影响。
- 若能证明远程医疗以更低成本维持医疗质量,此类干预的价值将最终提升。
研究设计与样本
- Cross等开展了一项随机对照试验,评估远程监测项目对炎症性肠病患者的影响。
主要发现
- 远程监测组与对照组在疾病活动度方面未显示差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Telemedicine can take a number of forms. A popular approach is the use of telemonitoring, which takes advantage of available technology to follow patients remotely. Cross and colleagues present the results of a well-done randomized controlled trial to assess the impact of a telemonitoring program for patients with inflammatory bowel disease. They did not show a difference in disease activity, but this study leads us to question whether we know the appropriate outcomes to follow for telemedicine interventions. If we can show that telemedicine maintains quality of care at lower costs, the value of these types of interventions will ultimately be increased.
引用
- Siegel CA. Placing Value on Telemedicine for Inflammatory Bowel Disease. Am J Gastroenterol. 2019. PMID: 30768428. doi:10.14309/ajg.0000000000000151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。